Bouchal Jan Ph.D., Assoc. Prof.
Journals
Olaparib is effective in combination with, and as maintenance therapy after, first-line endocrine therapy in prostate cancer cells.
Molecular Oncology.
2018,
12(4),
561-576,
ISSN: 1574-7891,
PMID: 29465803,